AU2002234729A1 - Method for identifying compounds modulating reverse cholesterol transport - Google Patents

Method for identifying compounds modulating reverse cholesterol transport

Info

Publication number: AU2002234729A1
Authority: AU; Australia
Prior art keywords: identifying compounds; cholesterol transport; reverse cholesterol; compounds modulating; modulating reverse
Prior art date: 2001-02-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002234729A

Other versions

AU2002234729B2 (en

Inventor

Bart Staels

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genfit SA

Original Assignee

Genfit SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-05

Filing date

2002-02-04

Publication date

2003-02-13

2001-02-05 Priority claimed from FR0101486A external-priority patent/FR2820435B1/en

2002-02-04 Application filed by Genfit SA filed Critical Genfit SA

2003-02-13 Publication of AU2002234729A1 publication Critical patent/AU2002234729A1/en

2007-05-31 Application granted granted Critical

2007-05-31 Publication of AU2002234729B2 publication Critical patent/AU2002234729B2/en

2022-02-04 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002234729A 2001-02-05 2002-02-04 Method for identifying compounds modulating reverse cholesterol transport Ceased AU2002234729B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0101486A FR2820435B1 (en)	2001-02-05	2001-02-05	METHODS OF IDENTIFYING COMPOUNDS MODULATING THE REVERSE TRANSPORT OF CHOLESTEROL
FR01/01486		2001-02-05
PCT/FR2002/000410 WO2002063038A1 (en)	2001-02-05	2002-02-04	Method for identifying compounds modulating reverse cholesterol transport

Publications (2)

Publication Number	Publication Date
AU2002234729A1 true AU2002234729A1 (en)	2003-02-13
AU2002234729B2 AU2002234729B2 (en)	2007-05-31

Family

ID=8859595

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002234729A Ceased AU2002234729B2 (en)	2001-02-05	2002-02-04	Method for identifying compounds modulating reverse cholesterol transport

Country Status (14)

Country	Link
US (1)	US20040115666A1 (en)
EP (1)	EP1358354B1 (en)
JP (1)	JP2004537272A (en)
KR (1)	KR20030074740A (en)
CN (1)	CN1568374A (en)
AT (1)	ATE321887T1 (en)
AU (1)	AU2002234729B2 (en)
CA (1)	CA2437434A1 (en)
DE (1)	DE60210253T2 (en)
DK (1)	DK1358354T3 (en)
ES (1)	ES2260413T3 (en)
FR (1)	FR2820435B1 (en)
IL (1)	IL156218A0 (en)
WO (1)	WO2002063038A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050159362A1 (en) *	2003-04-22	2005-07-21	Sircar Jagadish C.	Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
FR2864105B1 (en) *	2003-12-23	2008-02-01	Genfit S A	METHOD FOR IDENTIFYING COMPOUNDS THAT MODULATE THE REVERSE TRANSPORT OF CHOLESTEROL
CA2568539A1 (en) *	2004-06-09	2005-12-29	Avanir Pharmaceuticals	Small molecules for treatment of hypercholesterolemia and related diseases
WO2005123770A1 (en) *	2004-06-09	2005-12-29	Avanir Pharmaceuticals	Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
AU2005255011A1 (en) *	2004-06-09	2005-12-29	Avanir Pharmaceuticals	Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
KR100784859B1 (en) *	2005-01-14	2007-12-14	한국과학기술연구원	Analysis method of interaction of Panesoid Ｘ receptor-ligand complex and detection of binding inhibitor using fluorescence polarization
WO2007055873A2 (en) *	2005-11-04	2007-05-18	Avanir Pharmaceuticals	Process for the manufacture of peptide facilitators of reverse cholesterol transport

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5721096A (en) *	1991-01-24	1998-02-24	Children's Medical Center Corporation	Methods of screening for compounds with ability to alter apolipoprotein AI gene expression
DE19709125A1 (en) *	1997-03-06	1998-09-10	Bayer Ag	Substituted quinolines
JP2000109455A (en) *	1998-08-06	2000-04-18	Shionogi & Co Ltd	Compound having accelerating action on expression of apolipoprotein ai gene
WO2000040965A1 (en) *	1999-01-07	2000-07-13	Tularik, Inc.	Fxr receptor-mediated modulation of cholesterol metabolism
DE60013417T2 (en) *	1999-03-26	2005-09-15	City Of Hope, Duarte	Method for screening FXR receptor modulators
US20020132223A1 (en) *	1999-03-26	2002-09-19	City Of Hope	Methods for modulating activity of the FXR nuclear receptor

2001
- 2001-02-05 FR FR0101486A patent/FR2820435B1/en not_active Expired - Fee Related
2002
- 2002-02-04 EP EP02701394A patent/EP1358354B1/en not_active Expired - Lifetime
- 2002-02-04 CN CNA028035097A patent/CN1568374A/en active Pending
- 2002-02-04 DK DK02701394T patent/DK1358354T3/en active
- 2002-02-04 ES ES02701394T patent/ES2260413T3/en not_active Expired - Lifetime
- 2002-02-04 AT AT02701394T patent/ATE321887T1/en not_active IP Right Cessation
- 2002-02-04 JP JP2002562774A patent/JP2004537272A/en active Pending
- 2002-02-04 KR KR10-2003-7009863A patent/KR20030074740A/en not_active Ceased
- 2002-02-04 WO PCT/FR2002/000410 patent/WO2002063038A1/en not_active Ceased
- 2002-02-04 IL IL15621802A patent/IL156218A0/en unknown
- 2002-02-04 AU AU2002234729A patent/AU2002234729B2/en not_active Ceased
- 2002-02-04 CA CA002437434A patent/CA2437434A1/en not_active Abandoned
- 2002-02-04 US US10/450,257 patent/US20040115666A1/en not_active Abandoned
- 2002-02-04 DE DE60210253T patent/DE60210253T2/en not_active Expired - Fee Related

Similar Documents

Publication	Publication Date	Title
AU2002300036A1 (en)	2003-06-12	Method for creating a workflow
AU2002303584A1 (en)	2002-11-18	Method for identifying comparable instruments
AU2002331831A1 (en)	2003-03-24	Compounds and methods for fluorescent labeling
AU3448400A (en)	2000-10-04	Method for communicating information
AU2002366560A1 (en)	2003-06-23	Method for gasket removal
AU2002234729A1 (en)	2003-02-13	Method for identifying compounds modulating reverse cholesterol transport
AU2002349699A1 (en)	2003-06-17	Pipeline transportation method for lase-of-polymerization liquid
AU2002247215A1 (en)	2002-09-04	Method for screening compounds
AU2002244274A1 (en)	2002-10-08	Method for data broadcasting
AU2002325855A1 (en)	2003-07-03	Method for reconditioning rollers
AU2002367917A1 (en)	2003-12-19	Method for identifying interaction partners using phage display
AU2002303545A1 (en)	2002-11-11	Method for identifying lymph nodes
AU2002315671A1 (en)	2002-11-18	Method for automatically relaying information
AU2002317093A1 (en)	2003-01-21	Screening processes for agents modulating cholesterol levels
AU2001258680A1 (en)	2003-06-23	Method for identifying biochemical material
AU4856501A (en)	2001-10-30	Screening method for compounds
AU2000255630A1 (en)	2001-10-08	Method for identifying uv-filter compounds
AU2002353937A1 (en)	2003-06-23	Common method for communicating area information
AU5731800A (en)	2000-12-28	Method for identifying compounds which affect synaptogenesis
AU2002336796A1 (en)	2003-05-12	Method for identifying transport proteins
AU2003214103A1 (en)	2003-09-22	Method for identifying specific rna-inhibitors
AUPR379101A0 (en)	2001-04-12	Method for distributing information
AU2002233150A1 (en)	2003-07-09	Method for executing push services
AU2002242668A1 (en)	2002-07-24	Method for rock-chiseling
AU2002356777A1 (en)	2003-07-15	Method for continuous graphitization